ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
147 hedge funds and large institutions have $852M invested in Achillion Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 153 → 147 (-6)
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
Holders
147
Holding in Top 10
3
Calls
$10M
Puts
$3.6M
Top Buyers
| 1 | +$10.8M | |
| 2 | +$5.69M | |
| 3 | +$3.95M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.55M |
| 5 |
O
OrbiMed
New York
|
+$1.26M |
Top Sellers
| 1 | -$8.32M | |
| 2 | -$5.61M | |
| 3 | -$5.21M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$4.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.27M |